The European challenges of funding orphan medicinal products

The European challenges of funding orphan medicinal products

Abstract Background Funding of orphan medicinal products (OMPs) is an increasing challenge in the European Union (EU). Objectives To identify the different methods for public funding of OMPs in order to map the availability for rare disease patients, as well as to compare the public expenditures on...

Full description

Bibliographic Details
Main Authors: Márta Szegedi, Tamás Zelei, Francis Arickx, Anna Bucsics, Emanuelle Cohn-Zanchetta, Jurij Fürst, Maria Kamusheva, Pawel Kawalec, Guenka Petrova, Juraj Slaby, Ewa Stawowczyk, Milan Vocelka, Ingrid Zechmeister-Koss, Zoltán Kaló, Mária Judit Molnár
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Orphan medicinal products
Funding
Reimbursement
Patient access
Equity
European Union
Online Access:http://link.springer.com/article/10.1186/s13023-018-0927-y

Internet

http://link.springer.com/article/10.1186/s13023-018-0927-y

Similar Items